In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

Nathaniel S. Hwang, Shyni Varghese, H. Janice Lee, Zijun Zhang, Zhaohui Ye, Jongwoo Bae, Linzhao Cheng, Jennifer Hartt Elisseeff

Research output: Contribution to journalArticle

Abstract

Development of clinically relevant regenerative medicine therapies using human embryonic stem cells (hESCs) requires production of a simple and readily expandable cell population that can be directed to form functional 3D tissue in an in vivo environment. We describe an efficient derivation method and characterization of mesenchymal stem cells (MSCs) from hESCs (hESCd-MSCs) that have multilineage differentiation potential and are capable of producing fat, cartilage, and bone in vitro. Furthermore, we highlight their in vivo survival and commitment to the chondrogenic lineage in a microenvironment comprising chondrocyte-secreted morphogenetic factors and hydrogels. Normal cartilage architecture was established in rat osteochondral defects after treatment with chondrogenically-committed hESCd-MSCs. In view of the limited available cell sources for tissue engineering applications, these embryonic-derived cells show significant potential in musculoskeletal tissue regeneration applications.

Original languageEnglish (US)
Pages (from-to)20641-20646
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number52
DOIs
StatePublished - Dec 30 2008

Fingerprint

Mesenchymal Stromal Cells
Regeneration
Cartilage
Hydrogels
Regenerative Medicine
Tissue Engineering
Chondrocytes
Fats
Bone and Bones
Population
Human Embryonic Stem Cells
Therapeutics

Keywords

  • Cartilage
  • Differentiation
  • Hydrogel
  • Tissue engineering

ASJC Scopus subject areas

  • General

Cite this

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. / Hwang, Nathaniel S.; Varghese, Shyni; Lee, H. Janice; Zhang, Zijun; Ye, Zhaohui; Bae, Jongwoo; Cheng, Linzhao; Elisseeff, Jennifer Hartt.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 52, 30.12.2008, p. 20641-20646.

Research output: Contribution to journalArticle

@article{2a591969c95641029b5a204bc597554c,
title = "In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells",
abstract = "Development of clinically relevant regenerative medicine therapies using human embryonic stem cells (hESCs) requires production of a simple and readily expandable cell population that can be directed to form functional 3D tissue in an in vivo environment. We describe an efficient derivation method and characterization of mesenchymal stem cells (MSCs) from hESCs (hESCd-MSCs) that have multilineage differentiation potential and are capable of producing fat, cartilage, and bone in vitro. Furthermore, we highlight their in vivo survival and commitment to the chondrogenic lineage in a microenvironment comprising chondrocyte-secreted morphogenetic factors and hydrogels. Normal cartilage architecture was established in rat osteochondral defects after treatment with chondrogenically-committed hESCd-MSCs. In view of the limited available cell sources for tissue engineering applications, these embryonic-derived cells show significant potential in musculoskeletal tissue regeneration applications.",
keywords = "Cartilage, Differentiation, Hydrogel, Tissue engineering",
author = "Hwang, {Nathaniel S.} and Shyni Varghese and Lee, {H. Janice} and Zijun Zhang and Zhaohui Ye and Jongwoo Bae and Linzhao Cheng and Elisseeff, {Jennifer Hartt}",
year = "2008",
month = "12",
day = "30",
doi = "10.1073/pnas.0809680106",
language = "English (US)",
volume = "105",
pages = "20641--20646",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "52",

}

TY - JOUR

T1 - In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

AU - Hwang, Nathaniel S.

AU - Varghese, Shyni

AU - Lee, H. Janice

AU - Zhang, Zijun

AU - Ye, Zhaohui

AU - Bae, Jongwoo

AU - Cheng, Linzhao

AU - Elisseeff, Jennifer Hartt

PY - 2008/12/30

Y1 - 2008/12/30

N2 - Development of clinically relevant regenerative medicine therapies using human embryonic stem cells (hESCs) requires production of a simple and readily expandable cell population that can be directed to form functional 3D tissue in an in vivo environment. We describe an efficient derivation method and characterization of mesenchymal stem cells (MSCs) from hESCs (hESCd-MSCs) that have multilineage differentiation potential and are capable of producing fat, cartilage, and bone in vitro. Furthermore, we highlight their in vivo survival and commitment to the chondrogenic lineage in a microenvironment comprising chondrocyte-secreted morphogenetic factors and hydrogels. Normal cartilage architecture was established in rat osteochondral defects after treatment with chondrogenically-committed hESCd-MSCs. In view of the limited available cell sources for tissue engineering applications, these embryonic-derived cells show significant potential in musculoskeletal tissue regeneration applications.

AB - Development of clinically relevant regenerative medicine therapies using human embryonic stem cells (hESCs) requires production of a simple and readily expandable cell population that can be directed to form functional 3D tissue in an in vivo environment. We describe an efficient derivation method and characterization of mesenchymal stem cells (MSCs) from hESCs (hESCd-MSCs) that have multilineage differentiation potential and are capable of producing fat, cartilage, and bone in vitro. Furthermore, we highlight their in vivo survival and commitment to the chondrogenic lineage in a microenvironment comprising chondrocyte-secreted morphogenetic factors and hydrogels. Normal cartilage architecture was established in rat osteochondral defects after treatment with chondrogenically-committed hESCd-MSCs. In view of the limited available cell sources for tissue engineering applications, these embryonic-derived cells show significant potential in musculoskeletal tissue regeneration applications.

KW - Cartilage

KW - Differentiation

KW - Hydrogel

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=58549102321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549102321&partnerID=8YFLogxK

U2 - 10.1073/pnas.0809680106

DO - 10.1073/pnas.0809680106

M3 - Article

C2 - 19095799

AN - SCOPUS:58549102321

VL - 105

SP - 20641

EP - 20646

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 52

ER -